Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Eyepoint Inc.

United States 480 Pleasant Street, 02472-2463, United States

About the sponsor

Eyepoint Inc. focuses on clinical research in retinal disorders affecting central vision, with studies centered on diabetic macular edema and wet age-related macular degeneration.

  • Diabetic Macular Edema
  • Wet Age-Related Macular Degeneration
  • Macular pathology

Its research activity is concentrated in ophthalmology and the treatment of vision-threatening macular disease.

About Specializations

Eyepoint Inc. runs clinical trials in conditions such as Diabetic retinal oedema, Neovascular age-related macular degeneration, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Diabetic retinal oedema

Not recruiting
Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyepoint Inc.

Diabetic retinal oedema

Not recruiting
Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyepoint Inc.

Neovascular age-related macular degeneration

Not recruiting
Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Eyepoint Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.